[Home ] [Archive]   [ فارسی ]  
:: Main In Press Current Issue All Issues Search register ::
Main Menu
Home::
Journal Information::
Editorial Board::
Articles archive::
For Authors::
For Reviewers::
Editorial Policy::
Registration::
Contact us::
::
..
Indexing

 

 

 

 

 
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

..
:: Volume 18, Issue 3 (autumn 2018) ::
J Ardabil Univ Med Sci 2018, 18(3): 341-356 Back to browse issues page
The Economic Burden of Coronary Heart Disease in Iran: A Bottom-up Approach in 2014
Hossein Raghfar * , Nasrin Sargazi , Satar Mehraban , Mohammad Ali Akbarzadeh , Mohammad Reza Vaez Mahdavi , Zahra Vahdati Manesh
Department of Economics, School of Social Sciences and Economics, ALZahra University, Tehran, Iran , h.raghfar@alzahra.ac.ir
Abstract:   (6529 Views)
Background & objectives: cardiovascular diseases are the main cause of mortality around the whole world. However, there is limited information on its economic costs in Iran. The aim of this study was to evaluate the economic costs of coronary heart disease in Iran in 2014.
Methods: The diseases costs were calculated based on the incidence approach using a bottom-up method and a community-oriented perspective.   The drug cost information was obtained from angiographed patients (607 cases) in Shahid Modarres Hospital using simple random sampling method. Other information like disease incidence, distribution of patients, treatment patterns, length of stay and mortality rate was gathered from the literature, interview with patients, consultation with specialists, questionnaire, ministry of health and statistical center of Iran.
Results: Coronary heart diseases impose a significant economic burden in the range of 4,715 and 4,908 billion dollars (210,037,860,000,000-201,778,425,000,000 rials) upon Iran economic system. The medical costs and the costs of lost productivity due to premature death were calculated at USD 3.572 billion (152,863,740,000,000 rials) and USD 933 million (39,927,735,000,000 rials) respectively. The major part of medical costs was related to angioplasty costs (47%) and the minor part was related to drug costs (1.15%).
Conclusion: Coronary heart diseases impose a lot of financial costs to Iran healthcare system which cover more than 16% of whole healthcare financial costs. It is possible to streamline all consequential costs due to coronary heart disease by means of economic and effective use of resources and widespread self-care plan.
 
Keywords: Coronary Heart Disease, Cost-of-Illness, Economic Burden, Iran
Full-Text [PDF 289 kb]   (3325 Downloads)    
Type of Study: article | Subject: hygiene
Received: 2018/03/11 | Accepted: 2018/08/21 | Published: 2018/10/2
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Raghfar H, Sargazi N, Mehraban S, Akbarzadeh M A, Vaez Mahdavi M R, Vahdati Manesh Z. The Economic Burden of Coronary Heart Disease in Iran: A Bottom-up Approach in 2014 . J Ardabil Univ Med Sci 2018; 18 (3) :341-356
URL: http://jarums.arums.ac.ir/article-1-1505-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 3 (autumn 2018) Back to browse issues page
مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.18 seconds with 41 queries by YEKTAWEB 4623